Etiologic profile and antimicrobial susceptibility of community-acquired urinary tract infection in two Cameroonian towns.

BMC Research Notes
Jane-Francis Tatah Kihla AkoachereEsemu Nkie Seraphine

Abstract

Urinary tract infection (UTI) represents one of the most common diseases encountered in community medical practice. In resource poor settings, treatment is usually empiric due to the high cost and long duration required for reporting diagnosis by culture and antibiotic susceptibility testing. With the growing problem of drug resistance knowledge of antibiotic susceptibility pattern is pertinent for successful eradication of invading pathogens. Our study, the first of its kind in Cameroon, analyzed the distribution and antibiotic susceptibility of bacteria causing community-acquired urinary tract infection (CAUTI) in two towns (Bamenda and Buea) with a large number of young and middle aged persons, to provide data that could guide empiric treatment. We cultured 235 urine specimens and analyzed the antibiotic susceptibility of isolates by the disc diffusion technique. Uropathogens were recovered from 137 (58.3%), with prevalence rates in Buea and Bamenda being 65.9% and 54% respectively. Predominant pathogens were Escherichia coli (31.4%), Klebsiella oxytoca (25.5%) and Staphylococcus spp (24.1%). Geographic variation in uropathogen distribution and antibiotic susceptibility was observed, and a significant difference in pathogen ...Continue Reading

References

Jan 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C M Kunin
Aug 15, 1996·The New England Journal of Medicine·T M HootonW E Stamm
Mar 3, 1999·JAMA : the Journal of the American Medical Association·K GuptaW E Stamm
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J W WarrenW E Stamm
Feb 2, 2000·World Journal of Urology·C M Gonzalez, A J Schaeffer
Jul 10, 2003·Infectious Disease Clinics of North America·Kalpana Gupta
Apr 14, 2004·Tropical Medicine & International Health : TM & IH·Matthew F YuyunJimmy Zoung-Kanyi
May 6, 2005·Scandinavian Journal of Infectious Diseases·Bjørn BlombergTore Midtvedt
May 14, 2005·The Journal of Antimicrobial Chemotherapy·Jacques Albert DromignyJean David Perrier-Gros-Claude
Mar 24, 2007·Annals of Clinical Microbiology and Antimicrobials·Mohammed AkramAsad U Khan
Nov 26, 2008·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Eliana Biondi Medeiros GuidoniJulio Toporovski
May 1, 2009·Emerging Infectious Diseases·Etienne RuppéGuillaume Arlet
Jan 1, 2008·Journal of Infection in Developing Countries·Atul Kothari, Vishal Sagar
Feb 2, 2010·The Journal of Infection·Majdi N Al-HasanLarry M Baddour
Jul 20, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·P H A BoursA J Matute
Jun 10, 2011·Indian Journal of Nephrology·M EshwarappaP Kempegowda

❮ Previous
Next ❯

Citations

Feb 21, 2014·Revista Do Instituto De Medicina Tropical De São Paulo·Uju M E DibuaEmeka I Nweze
Mar 27, 2019·Journal of Environmental Science and Health. Part A, Toxic/hazardous Substances & Environmental Engineering·Priti ParalikarMahendra Rai
Aug 21, 2019·BMC Public Health·Mohamed Moctar Mouliom MouicheJulius Awah-Ndukum
Sep 27, 2016·International Journal of Microbiology·Rolf Nyah-Tuku NzalieSinata Koulla-Shiro
Oct 2, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Claujens Chastel Mfoutou MapanguyFrancine Ntoumi

❮ Previous
Next ❯

Software Mentioned

Minitab
MS Excel

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.